Emro Inc.
EMRO., Incorporated. provides supply chain management software in South Korea and internationally. The company offers procurement and purchase solutions, including SMARTcms, a classification and information management solution; SMARTvs, a credit rating linkage agencies solution; SMARTsrm, an evaluation system for program application; SMARTrisk, a risk monitoring system for financial/non-financial… Read more
Emro Inc. (058970) - Total Liabilities
Latest total liabilities as of September 2025: ₩22.37 Billion KRW
Based on the latest financial reports, Emro Inc. (058970) has total liabilities worth ₩22.37 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Emro Inc. - Total Liabilities Trend (2016–2024)
This chart illustrates how Emro Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Emro Inc. Competitors by Total Liabilities
The table below lists competitors of Emro Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nueva Expresión Textil S.A.
MC:NXT
|
Spain | €51.93 Million |
|
Tongyang 3PB Preffered
KO:001529
|
Korea | ₩601.94 Billion |
|
San Fang Chemical Industry Co Ltd
TW:1307
|
Taiwan | NT$7.54 Billion |
|
Computer Programs and Systems Inc
F:PS1
|
Germany | €219.05 Million |
|
Inmobiliaria del Sur SA
MC:ISUR
|
Spain | €352.61 Million |
|
Zeng Hsing Industrial Co Ltd
TW:1558
|
Taiwan | NT$4.64 Billion |
|
Duksan Hi Metal Co.Ltd
KQ:077360
|
Korea | ₩353.87 Billion |
|
SENORES PHARMACEUTICALS L
NSE:SENORES
|
India | ₹4.54 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Emro Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Emro Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Emro Inc. (2016–2024)
The table below shows the annual total liabilities of Emro Inc. from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩13.43 Billion | -78.60% |
| 2023-12-31 | ₩62.75 Billion | +172.74% |
| 2022-12-31 | ₩23.01 Billion | +62.45% |
| 2021-12-31 | ₩14.16 Billion | -38.70% |
| 2020-12-31 | ₩23.10 Billion | -19.82% |
| 2019-12-31 | ₩28.82 Billion | +63.36% |
| 2018-12-31 | ₩17.64 Billion | +7.98% |
| 2017-12-31 | ₩16.34 Billion | +22.73% |
| 2016-12-31 | ₩13.31 Billion | -- |